Get startedLog in
    Picture of ImmuneOnco Biopharmaceuticals (Shanghai) logo

    1541 — ImmuneOnco Biopharmaceuticals (Shanghai) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: ImmuneOnco Biopharmaceuticals Shanghai Receives Approval From NMPA China For Investigational New Drug Application Of IMM0306S

    Picture of ImmuneOnco Biopharmaceuticals (Shanghai) logoImmuneOnco Biopharmaceuticals (Shanghai)
    06/03/2026 16:11
    March 6 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:

APPROVAL FROM NMPA CHINA FOR INVESTIGATIONAL NEW DRUG APPLICATION OF IMM0306S (SUBCUTANEOUS FORMULATION)

Further company coverage: 1541.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)

    See all news